InChI=1S/C27H44O4/c1-15-7-10-27(30-14-15)16(2)24-22(31-27)13-21-19-6-5-17-11-18(28)12-23(29)26(17,4)20(19)8-9-25(21,24)3/h15-24,28-29H,5-14H2,1-4H3/t15-,16+,17-,18+,19-,20+,21+,22+,23-,24+,25+,26+,27-/m1/s1 |
NCLLSOCDVMFDSK-FQXYYZOXSA-N |
[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@@]4(C)[C@@]3([H])C[C@]3([H])O[C@]5(CC[C@@H](C)CO5)[C@@H](C)[C@]43[H])[C@@]1(C)[C@H](O)C[C@@H](O)C2 |
|
(25R)-5β-spirostan-1β,3α-diol
|
(25R)-5β-spirostane-1β,3α-diol
|
ChEBI
|
|
2006-03-20
|
As reported in New J. Chem., 2006, 30, 197-207. The possibility of the reported compound being the enantiomer, (25S)-5α-spirostan-1α,3β-diol, cannot be discounted.
|
|
|
|